*****ON THE WATCHLIST FOR NEXT WEEK AS STOCK HAS BEEN ACTING QUITE BULLISH IN RECENT DAYS***** CAMBRIDGE, Mass., May 29, 2019 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (INFI) announced today that members of the management team will be participating in the 2019 BIO International Convention at Pennsylvania Convention Center, Philadelphia, PA. Adelene Perkins, Infinity Pharmaceutical's Chief Executive Officer, will provide a company overview on Tuesday, June 4, 2019, at 2:45 p.m. ET. A live webcast of the presentation will be available on the Investors/Media section of Infinity's website at infi.com, and will be available for 30 days following the event.
AVERAGE ANALYSTS PRICE TARGET $3 AVERAGE ANALYSTS RECOMMENDATION HOLD
COMPANY PROFILE Infinity Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in discovering, developing and delivering medicines for people with cancer. It focuses on drug development. The company was founded by Steven H. Holtzman on March 22, 1995 and is headquartered in Cambridge, MA.